An auristatin-based antibody-drug conjugate targeting EphA2 in pancreatic cancer treatment
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
An auristatin-based antibody-drug conjugate targeting EphA2 in pancreatic cancer treatment
Authors
Keywords
-
Journal
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Volume -, Issue -, Pages 149214
Publisher
Elsevier BV
Online
2023-11-03
DOI
10.1016/j.bbrc.2023.149214
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Chronological Change in EPHA2 Protein Expression Is Associated With Recurrence of Bladder Cancer
- (2022) MITSUYUKI KOIZUMI et al. ANTICANCER RESEARCH
- Enriched cancer stem cells, dense stroma, and cold immunity: Interrelated events in pancreatic cancer
- (2021) Keywan Mortezaee JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY
- Benefits and challenges of antibody drug conjugates as novel form of chemotherapy
- (2021) Syeda Warisul Fatima et al. JOURNAL OF CONTROLLED RELEASE
- Antibody–Drug Conjugate Payloads; Study of Auristatin Derivatives
- (2020) Michinori Akaiwa et al. CHEMICAL & PHARMACEUTICAL BULLETIN
- Understanding the immune landscape and tumor microenvironment of pancreatic cancer to improve immunotherapy
- (2020) Robert J. Torphy et al. MOLECULAR CARCINOGENESIS
- Antibody–Drug Conjugates for Cancer Treatment
- (2018) John M. Lambert et al. Annual Review of Medicine
- Preclinical Efficacy of Anti-RON Antibody–Drug Conjugate Zt/g4-MMAE for Targeted Therapy of Pancreatic Cancer Overexpressing RON Receptor Tyrosine Kinase
- (2018) Hang-Ping Yao et al. MOLECULAR PHARMACEUTICS
- Quantitative characterization of in vitro bystander effect of antibody-drug conjugates
- (2016) Aman P. Singh et al. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
- Antibody–drug conjugates for cancer therapy
- (2016) Anish Thomas et al. LANCET ONCOLOGY
- Antibody-drug conjugates as novel anti-cancer chemotherapeutics
- (2015) C. Peters et al. BIOSCIENCE REPORTS
- A novel humanized anti-HER2 antibody conjugated with MMAE exerts potent anti-tumor activity
- (2015) Xuejing Yao et al. BREAST CANCER RESEARCH AND TREATMENT
- Antitumor effect of antitissue factor antibody-MMAE conjugate in human pancreatic tumor xenografts
- (2015) Yoshikatsu Koga et al. INTERNATIONAL JOURNAL OF CANCER
- Therapeutic targeting of EPH receptors and their ligands
- (2013) Andrew W. Boyd et al. NATURE REVIEWS DRUG DISCOVERY
- Molecular markers associated with outcome and metastasis in human pancreatic cancer
- (2012) Anke Van den Broeck et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Inhibition of Cell Migration and Cell Division Correlates with Distinct Effects of Microtubule Inhibiting Drugs
- (2010) Hailing Yang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A Human Antibody-Drug Conjugate Targeting EphA2 Inhibits Tumor Growth In vivo
- (2008) D. Jackson et al. CANCER RESEARCH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started